Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.

about

miR-503 suppresses the proliferation and metastasis of esophageal squamous cell carcinoma by triggering autophagy via PKA/mTOR signaling.MicroRNA-6852 suppresses cell proliferation and invasion via targeting forkhead box J1 in gastric cancer

P2860

Q52641340-7A29BF61-56A3-4368-9870-3434E82726A9 Q58802789-F1F34781-EBC1-4703-AAB1-942074300148

P2860

Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.

Item

http://www.wikidata.org/entity/Q42370321

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Circulating microRNAs in patie ...... cancer treated with dovitinib.

@en

Circulating microRNAs in patie ...... cancer treated with dovitinib.

@nl

type

Item

label

Circulating microRNAs in patie ...... cancer treated with dovitinib.

@en

Circulating microRNAs in patie ...... cancer treated with dovitinib.

@nl

prefLabel

Circulating microRNAs in patie ...... cancer treated with dovitinib.

@en

Circulating microRNAs in patie ...... cancer treated with dovitinib.

@nl

P1476

Circulating microRNAs in patie ...... cancer treated with dovitinib

@en

P2093

Erin Carney

http://www.w3.org/2001/XMLSchema#string

Eveline E Vietsch

http://www.w3.org/2001/XMLSchema#string

Narayan Shivapurkar

http://www.w3.org/2001/XMLSchema#string

P2860

Secretory mechanisms and intercellular transfer of microRNAs in living cells

Circulating biomarkers to monitor cancer progression and treatment

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases

Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer

Circulating MiR-125b as a marker predicting chemoresistance in breast cancer

Fibroblast growth factor signalling: from development to cancer

Endogenous human microRNAs that suppress breast cancer metastasis

P2888

s40169-017-0169-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40169-017-0169-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anton Wellstein

Claudine Isaacs

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092054481

http://www.w3.org/2001/XMLSchema#string

P698

28980224

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

P932

5628092

http://www.w3.org/2001/XMLSchema#string

Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.

about

P2860

P2860

Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932